TCRX logo
TCRX NASDAQ US

TScan Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jul 2021
$1.01
▼ $-0.02 (-1.94%)
Vol 673K
3
Quality Score
fail
Mkt Cap
$56.7M
ROE
-73.9%
Margin
-1693.0%
D/E
22.51
Beta
1.09
52W
$1–$3

Wall Street Consensus

13 analysts · Apr 2026
3
Strong Buy
7
Buy
3
Hold
0
Sell
0
Strong Sell
76.9%
Buy Rating

Price Chart

Similar Stocks

OKUR
Onkure Therapeutics Inc
$39.3M
ICCC
ImmuCell Corp
P/E 23.9
$55.6M
TIL
Instil Bio Inc
$74.6M
KZR
Kezar Life Sciences Inc
$46.1M
MGX
Metagenomi Therapeutics Inc
$60.8M
INKT
Mink Therapeutics Inc
$52.3M
ELUT
Elutia Inc
$29.6M
HOWL
Werewolf Therapeutics Inc
$30.8M

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.25 $-0.18 +$0.07
Sep 2025 $-0.30 $-0.28 +$0.02
Jun 2025 $-0.29 $-0.28 +$0.01
Mar 2025 $-0.29 $-0.26 +$0.03

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -63.8% -63.8% -63.8% -63.8% -73.9% -73.9%
P/E (TTM) — — — — — —
Net Margin -1201.3% -1964.9% -1964.9% -1964.9% -1693.0% -1693.0%
Gross Margin — — — — — —
D/E Ratio 18.28 18.28 18.28 18.28 22.51 22.51
Current Ratio 7.06 7.06 7.06 7.06 6.44 6.44

Key Ratios

ROA (TTM)
-45.1%
P/S (TTM)
6.74
P/B
0.7
EPS (TTM)
$-1.12
CF/Share
$-1.74
Rev Growth 3Y
-34.8%
52W High
$3.43
52W Low
$0.88
$0.88 52-Week Range $3.43

How does TCRX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

TCRX AAPG ABEO ABOS ABP

TCRX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
6.7
▼ 48% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.7
▼ 71% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

TCRX profitability vs Biotechnology peers

ROE
-73.9%
▼ 10% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-1693.0%
▼ 490% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-45.1%
▲ 3% above peers (-46.7%)
vs Peers
vs Industry
In line

TCRX financial health vs Biotechnology peers

D/E ratio
22.5
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
6.4
▲ 45% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
1.1
▲ 12% above peers (1.0)
vs Peers
vs Industry
Less volatile

TCRX fundamentals radar

TCRX Peer median Industry

TCRX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TCRX vs peers: key metrics

Latest News

No related news yet